BridgeMD
New treatment option for Stroke
Official title The Effects of Home-based Graded Repetitive Arm Supplementary Program Group on Stroke.
ClinicalTrials.gov ID: NCT06883357
What this study is testing
- What it's testing
- Graded repetitive arm supplementary program (GRASP) is a self administrated, home-based rehabilitation program and has been incorporated in Canadian Stroke Best Practice Recommendations. Past studies indicated that the home-based GRASP program could facilitate the motor function and motor recovery and prevent learned nonuse of affected upper limb of stroke patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- Age is above 20 years old.
- Onset of first stroke complicated with hemiplegia or hemiparesis.
- The affected upper limb remains partially voluntary movements including lifting to chest level and holding for five seconds; slight flexion and...
- Understanding and complying with two-steps commands.
- Understanding the content of trial and willing to sign informed consent.
You likely can't join if
- Complicating with other neurological disease.
- Having Orthopedic diseases affecting the movements of upper limbs.
- Having symptoms of pain to affect the movements of upper limbs.
- Unstable vital sign or medical condition.
- Participating another rehabilitative or drug research meanwhile.
- Receiving botulinum toxin injection within three months.
The study team makes the final eligibility decision.
Where it's taking place
- Hsinchu, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hsinchu, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.